Latest News

Azacitadine May Be Safe, Effective for Older Patients with Acute Myeloid Leukemia

Azacitadine May Be Safe, Effective for Older Patients with Acute Myeloid Leukemia

Azacitadine may be an important treatment option for older patients with newly diagnosed acute myeloid leukemia (AML).

Addition of Levetiracetam May Improve Survival for Glioblastoma

Addition of Levetiracetam May Improve Survival for Glioblastoma

Levetiracetam may provide a survival benefit in patients with glioblastoma who receive temozolomide-based chemotherapy.

Gender Disparity in Receipt of End-of-Life Care

Gender Disparity in Receipt of End-of-Life Care

There are gender differences in receipt of end-of-life (EoL) care among terminally ill cancer patients.

Family History Alone May Not Affect Breast Cancer Treatment Outcomes

Family History Alone May Not Affect Breast Cancer Treatment Outcomes

A positive family history is not a significant independent risk factor for breast cancer outcome.

Surgery Before Chemotherapy Beneficial in Advanced Ovarian Cancer

Surgery Before Chemotherapy Beneficial in Advanced Ovarian Cancer

Undergoing chemotherapy before surgery may help women battling advanced ovarian cancer.

Tumor Infiltrating Lymphocytes Play Prognostic Role in Triple Negative Breast Cancer

Tumor Infiltrating Lymphocytes Play Prognostic Role in Triple Negative Breast Cancer

The prognostic role of tumor infiltrating lymphocytes (TIL) has been confirmed in triple negative early breast cancer.

Bronchial Genomic Classifier May Improve Lung Cancer Detection

Bronchial Genomic Classifier May Improve Lung Cancer Detection

Gene-expression classifier may improve the diagnostic performance of bronchoscopy in detecting lung cancer.

VCD Regimen Preferable as Induction for Newly Diagnosed Multiple Myeloma

VCD Regimen Preferable as Induction for Newly Diagnosed Multiple Myeloma

Bortezomib, cyclophosphamide, and dexamethasone (VCD) is preferable as induction therapy for newly diagnosed multiple myeloma.

Oncologist Recommendations, Motivation Package Increase Exercise Rate

Oncologist Recommendations, Motivation Package Increase Exercise Rate

For breast and colorectal cancer survivors, level of exercise participation significantly increased with oncologist recommendations.

Not All Dense Breasts Signify High Risk of Interval Cancer

Not All Dense Breasts Signify High Risk of Interval Cancer

Not all women with high breast density have high risk of interval cancer.

Stereotactic Ablative Radiotherapy May Be Feasible for Non-Small Cell Lung Cancer

Stereotactic Ablative Radiotherapy May Be Feasible for Non-Small Cell Lung Cancer

Stereotactic ablative radiotherapy could be an option for treating patients with operable stage I non-small cell lung cancer (NSCLC).

Vismodegib May Benefit Patients with Basal Cell Carcinoma

Vismodegib May Benefit Patients with Basal Cell Carcinoma

Treatment with vismodegib, a Hedgehog pathway inhibitor, may substantially benefit patients with advanced basal cell carcinoma.

Oxidative Damage May Lead to Neurocognitive Decline

Oxidative Damage May Lead to Neurocognitive Decline

Oxidative damage may contribute to chemotherapy-associated neurocognitive decline in survivors of childhood acute lymphoblastic leukemia (ALL).

Intensive Local Therapy to Renal Cell Carcinoma Bone Metastases May Increase Survival

Intensive Local Therapy to Renal Cell Carcinoma Bone Metastases May Increase Survival

Intensive local therapy to bone lesions in patients with renal cell carcinoma (RCC) with bone metastases may improve survival.

Metastasectomy May Raise Survival in Metastatic Renal Cell Carcinoma

Metastasectomy May Raise Survival in Metastatic Renal Cell Carcinoma

Complete metastasectomy may have a role in improving survival among patients with metastatic renal cell carcinoma (mRCC).

Larger Renal Cell Carcinoma Tumors Predict High-Grade Pathology

Larger Renal Cell Carcinoma Tumors Predict High-Grade Pathology

Larger tumor size is associated with high-grade pathology in patients with pT1a renal cell carcinoma (RCC).

Sonidegib 200 mg May Offer New Treatment Option for Basal Cell Carcinoma

Sonidegib 200 mg May Offer New Treatment Option for Basal Cell Carcinoma

The benefit-to-risk profile of 200mg sonidegib might offer a new treatment option for patients with advanced basal cell carcinoma.

Regorafenib Improves Survival in Treatment-Refractory Colorectal Cancer

Regorafenib Improves Survival in Treatment-Refractory Colorectal Cancer

Compared with placebo, regorafenib improved overall survival in patients with treatment-refractory metastatic colorectal cancer.

Digital Rectal Exams Have Limited Value for Prostate Cancer Screening

Digital Rectal Exams Have Limited Value for Prostate Cancer Screening

Digital rectal examinations (DREs) have questionable utility for detecting clinically significant prostate cancer (PCa).

Post-Prostatectomy Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

Post-Prostatectomy Outcomes Differ for Gleason 8, 9-10 Prostate Cancer

Patients with Gleason 9 or 10 prostate tumors have worse oncologic outcomes after radical prostatectomy (RP).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs